HUTCHMED (China) Ltd Files 6-K Report
Ticker: HMDCF · Form: 6-K · Filed: Dec 17, 2025 · CIK: 1648257
| Field | Detail |
|---|---|
| Company | Hutchmed (China) LTD (HMDCF) |
| Form Type | 6-K |
| Filed Date | Dec 17, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer
TL;DR
HUTCHMED (China) Ltd filed a 6-K on 12/17/25, standard foreign issuer report.
AI Summary
HUTCHMED (China) Limited, formerly Hutchison China MediTech Ltd, filed a Form 6-K on December 17, 2025. This report is for the month of December 2025 and indicates the company is a foreign private issuer filing under the Securities Exchange Act of 1934. The company's principal executive offices are located in Hong Kong.
Why It Matters
This filing provides routine updates for HUTCHMED (China) Limited, a pharmaceutical company, which is important for investors tracking its regulatory compliance and corporate actions.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that typically contains updates and does not represent a significant event or change in the company's financial or operational status.
Key Players & Entities
- HUTCHMED (China) Limited (company) — Registrant
- Hutchison China MediTech Ltd (company) — Former company name
- 20251217 (date) — Filing date
- December 2025 (date) — Reporting period
- 001-37710 (other) — SEC File Number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the company makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.
When was HUTCHMED (China) Limited previously known by another name?
HUTCHMED (China) Limited was formerly known as Hutchison China MediTech Ltd, with a date of name change on July 16, 2015.
Where are HUTCHMED (China) Limited's principal executive offices located?
The company's principal executive offices are located at 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong.
What is the SEC file number for HUTCHMED (China) Limited?
The SEC file number for HUTCHMED (China) Limited is 001-37710.
Does HUTCHMED (China) Limited file annual reports under Form 20-F or 40-F?
HUTCHMED (China) Limited indicates it files annual reports under cover of Form 20-F, as indicated by the check mark next to it.
Filing Stats: 172 words · 1 min read · ~1 pages · Grade level 13.8 · Accepted 2025-12-17 06:04:49
Filing Documents
- hcm-20251217x6k.htm (6-K) — 22KB
- hcm-20251217xex99d1.htm (EX-99.1) — 23KB
- hcm-20251217xex99d1001.gif (GRAPHIC) — 4KB
- 0001648257-25-000085.txt ( ) — 51KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of December 2025 Commission File Number: 001-37710 HUTCHMED (CHINA) LIMITED (Translation of registrant's name into English) 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F HUTCHMED (CHINA) LIMITED Form 6-K EXHIBIT INDEX Exhibit No. Description Exhibit 99.1 Press release relating to the initiation of global clinical development of ATTC c andidate HMPL-A251 in patients with solid tumors 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. HUTCHMED (CHINA) LIMITED By: /s/ Johnny Cheng Name: Johnny Cheng Title: Chief Financial Officer Date: December 17, 2025 3